Skip to main content

Advertisement

Log in

The diagnosis and treatment of subependymal giant cell astrocytoma combined with tuberous sclerosis

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Background

Subependymal giant cell astrocytoma develops in a small proportion of tuberous sclerosis patients. There are still several controversies on the early diagnosis of the tumor, treatment of hydrocephalus, and timing of operation, etc.

Methods

From September 1996 to April 2006, 17 patients were admitted in neurosurgical department of “Beijing Tiantan Hospital”. The authors analyzed medical records and followed up every case.

Results

There are 18 tumors out of 17 patients. One patient had double tumors. Sixteen patients except one underwent tumor resection 17 times. Fifteen tumors out of 17 were gross totally removed; two were partially removed. One patient died of brain infarction postoperatively. Three out of 13 patients with preoperative hydrocephalus still needed ventriculoperitoneal shunt after tumor resection. There was no recurrence after total resection.

Conclusion

Diagnosis of tumor should be made by clinical criteria. Serial follow-up is essential for a suspected perimonro lesion to find tumor growth earlier. When there is growth, tumor should be removed as soon as possible. Hydrocephalus will resolve in most cases after tumor resection, while external drainage is suitable for emergent cases. Transcallosal and transcortical approaches are both effective to resect the tumor. Tumor will not recur after total removal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jansen FE, van Nieuwenhuizen O, van Huffelen AC (2004) Tuberous sclerosis complex and its founders. J Neurol Neurosurg Psychiatry 75:770

    Article  CAS  PubMed  Google Scholar 

  2. Altman NR, Purser RK, Post MJ (1988) Tuberous sclerosis: characteristics at CT and MR imaging. Radiology 167:527–532

    CAS  PubMed  Google Scholar 

  3. Cuccia V, Zuccaro G, Sosa F, Monges J, Lubienieky F, Taratuto AL (2003) Subependymal giant cell astrocytoma in children with tuberous sclerosis. Childs Nerv Syst 19:232–243

    PubMed  Google Scholar 

  4. Goh S, Butler W, Thiele EA (2004) Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 63:1457–1461

    PubMed  Google Scholar 

  5. Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H, Kozma SC, Hafen E, Bos JL, Thomas G (2003) Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11:1457–1466

    Article  CAS  PubMed  Google Scholar 

  6. Curatolo P, Bombardieri R, Cerminara C (2006) Current management for epilepsy in tuberous sclerosis complex. Curr Opin Neuro l19:119–123

    Article  Google Scholar 

  7. de Ribaupierre S, Dorfmüller G, Bulteau C, Fohlen M, Pinard JM, Chiron C, Delalande O (2007) Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate? Neurosurgery 60:83–89

    PubMed  Google Scholar 

  8. Dashti SR, Robinson S, Rodgers M, Cohen AR (2005) Pineal region giant cell astrocytoma associated with tuberous sclerosis: case report. J Neurosurg 102(Suppl):322–325

    PubMed  Google Scholar 

  9. Nagib MG, Haines SJ, Erickson DL, Mastri AR (1984) Tuberous sclerosis: a review for the neurosurgeon. Neurosurgery 14:93–98

    Article  CAS  PubMed  Google Scholar 

  10. Conzen M, Oppel F (1990) Tuberous sclerosis in neurosurgery. An analysis of 18 patients. Acta Neurochir (Wien) 106:106–109

    Article  CAS  Google Scholar 

  11. Roach ES, DiMario FJ, Kandt RS, Northrup H (1999) Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J Child Neurol 14:401–407

    Article  CAS  PubMed  Google Scholar 

  12. Braffman BH, Bilaniuk LT, Naidich TP, Altman NR, Post MJ, Quencer RM, Zimmerman RA, Brody BA (1992) MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review. Radiology 183:227–238

    CAS  PubMed  Google Scholar 

  13. Nabbout R, Santos M, Rolland Y, Delalande O, Dulac O, Chiron C (1999) Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry 66:370–375

    Article  CAS  PubMed  Google Scholar 

  14. Bonnin JM, Rubinstein LJ, Papasozomenos SC, Marangos PJ (1984) Subependymal giant cell astrocytoma. Significance and possible cytogenetic implications of an immunohistochemical study. Acta Neuropathol 62:185–193

    Article  CAS  PubMed  Google Scholar 

  15. Di Rocco C, Iannelli A, Marchese E (1995) On the treatment of subependymal giant cell astrocytomas and associated hydrocephalus in tuberous sclerosis. Pediatr Neurosurg 23:115–121

    Article  PubMed  Google Scholar 

  16. Turgut M, Akalan N, Ozgen T, Ruacan S, Erbengi A (1996) Subependymal giant cell astrocytoma associated with tuberous sclerosis: diagnostic and surgical characteristics of five cases with unusual features. Clin Neurol Neurosurg 98:217–221

    Article  CAS  PubMed  Google Scholar 

  17. Shepherd CW, Gomez MR, Lie JT, Crowson CS (1991) Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66(8):792–796

    CAS  PubMed  Google Scholar 

  18. Shepherd CW, Gomez MR (1991) Mortality in the Mayo Clinic Tuberous Sclerosis Complex Study. Ann N Y Acad Sci 615:375–377

    Article  CAS  PubMed  Google Scholar 

  19. Prahlow JA, Teot LA, Lantz PE, Stanton CA (1995) Sudden death in epilepsy due to an isolated subependymal giant cell astrocytoma of the septum pellucidum. Am J Forensic Med Pathol 16:30–37

    Article  CAS  PubMed  Google Scholar 

  20. Fujiwara S, Takaki T, Hikita T, Nishio S (1989) Subependymal giant-cell astrocytoma associated with tuberous sclerosis. Do subependymal nodules grow? Childs Nerv Syst 5:43–44

    Article  CAS  PubMed  Google Scholar 

  21. Byard RW, Blumbergs PC, James RA (2003) Mechanisms of unexpected death in tuberous sclerosis. J Forensic Sci 48:172–176

    CAS  PubMed  Google Scholar 

  22. Sinson G, Sutton LN, Yachnis AT, Duhaime AC, Schut L (1994) Subependymal giant cell astrocytomas in children. Pediatr Neurosurg 20:233–239

    Article  CAS  PubMed  Google Scholar 

  23. Kumar R, Singh V (2004) Subependymal giant cell astrocytoma: a report of five cases. Neurosurg Rev 27:274–280

    PubMed  Google Scholar 

  24. Beems T, Grotenhuis JA (2001) Subependymal giant-cell astrocytoma in tuberous sclerosis: endoscopic images and the implications for therapy. Minim Invasive Neurosurg 44:58–60

    Article  CAS  PubMed  Google Scholar 

  25. Hyman MH, Whittemore VH (2000) National Institutes of Health consensus conference: tuberous sclerosis complex. Arch Neurol 57:662–665

    Article  CAS  PubMed  Google Scholar 

  26. Palmieri A, De Vecchio E, Pirolo R, Gardeur D, Ambrosio A (1982) The current potential of neuroradiology in the diagnosis of tuberous sclerosis. Ital J Neurol Sci 3:229–233

    Article  CAS  PubMed  Google Scholar 

  27. Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex. N Engl J Med 355:1345–56

    Article  CAS  PubMed  Google Scholar 

  28. Lee L, Sudentas P, Donohue B, Asrican K, Worku A, Walker V, Sun Y, Schmidt K, Albert MS, El-Hashemite N, Lader AS, Onda H, Zhang H, Kwiatkowski DJ, Dabora SL (2005) Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models. Genes Chromosom Cancer 42:213–27

    Article  CAS  PubMed  Google Scholar 

  29. Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, Dinopoulos A, Thomas G, Crone KR (2006) Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 59:490–498

    Article  CAS  PubMed  Google Scholar 

  30. Koenig MK, Butler IJ, Northrup H (2008) Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex. J Child Neurol 23:1238–1239

    Article  PubMed  Google Scholar 

  31. Muncy J, Butler IJ, Koenig MK (2009) Rapamycin reduces seizure frequency in tuberous sclerosis complex. J Child Neurol 24:477

    Article  PubMed  Google Scholar 

  32. Tarasewicz A, Debska-Slizień A, Konopa J, Zdrojewski Z, Rutkowski B (2009) Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex. Transplant Proc 41:3677–3682

    Article  CAS  PubMed  Google Scholar 

  33. Lam C, Bouffet E, Tabori U, Mabbott D, Taylor M, Bartels U (2010) Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors. Pediatr Blood Cancer 54:476–479

    Article  PubMed  Google Scholar 

  34. Wong M (2010) Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies. Epilepsia 51:27–36

    Article  CAS  PubMed  Google Scholar 

  35. Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, Cantley LC (2005) Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev 19:1773–1778

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to YuQi Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiang, T., Jia, G., Ma, Z. et al. The diagnosis and treatment of subependymal giant cell astrocytoma combined with tuberous sclerosis. Childs Nerv Syst 27, 55–62 (2011). https://doi.org/10.1007/s00381-010-1159-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-010-1159-1

Keywords

Navigation